Our results partially align with findings by Belloy and colleagues [11], who also reported a decreased risk of AD in individuals with the KL-VSHET haplotype, but only among APOE ε4 carriers, whereas we observed similar results for APOE ε4 carriers vs. non-carriers. This evidence concerns the gene APOE and Alzheimer disease.